Upcoming Briefing on Developing Medications to Treat Addiction

The Friends of the National Institute on Drug Abuse (NIDA) coalition is hosting a briefing organized by APA’s Science GRO, titled "Developing Medications to Treat Addiction: Implications for Policy and Practice," with speakers Nora D. Volkow, Director of NIDA, and A. Thomas McLellan, Deputy Director of the Office of National Drug Control Policy (ONDCP).

On May 11, the Friends of the National Institute on Drug Abuse (NIDA) coalition is hosting its fourteenth briefing (PDF, 15KB) as part of an ongoing series organized by APA’s Science GRO staff, to educate members of Congress about emerging research on drug abuse and addiction.  "Developing Medications to Treat Addiction: Implications for Policy and Practice" will discuss the opportunity for the development of new, effective pharmacotherapies in the context of breakthrough discoveries over the last decade and the anticipated changes in the healthcare system over the next several years. 

Nora D. Volkow, MD, Director of NIDA, will provide an overview of NIDA’s research, detailing opportunities for future advances.  A. Thomas McLellan, PhD, Deputy Director of the Office of National Drug Control Policy, will discuss policy and practice implications. 

The last decade has seen a profound transformation in understanding the mechanisms and consequences of drug abuse and addiction. Visit this web page (PDF, 170KB) to view a summary of NIDA’s research on medications development.

For more information on the briefing or to RSVP, please email Christine Jamieson.